Investigating the polyphenol bioequivalence of a spray-dried blackcurrant powder with a commercial blackcurrant extract and determining the acute effect of caffeine on the polyphenol bioavailability when co-consumed with blackcurrant powder in healthy participants.
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 9
研究概览
简要总结
The aim of this work was to evaluate the anthocyanin bioequivalence of a spray-dried blackcurrant powder with a commercially available anthocyanin-enriched blackcurrant extract and to determine the effect of caffeine on the bioavailability of spray-dried blackcurrant anthocyanins. Co-consuming caffeine with the spray-dried blackcurant powder did not significantly affect total or monomeric anthocyanin bioavailability up to 6 hours post consumption, as indicated by similar Tmax, Cmax and AUC, compared with consuming spray-dried blackcurant powder powder alone. Comparison of intervention bioavailability profiles showed a slower absorption of anthocyanins in the anthocyanin-enriched extract group as indicated by the Tmax after treatment intake. Despite this delay, no significant differences in Cmax and AUC were observed between the three blackcurrant interventions, indicating that the extent of anthocyanin bioavailability between three treatment groups is similar. The delayed Tmax observed in the encapsulated anthocyanin-enriched extract intervention may be attributed to the time taken for the gelatine capsule to disintegrate and release the blackcurrant powder in the stomach.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 55 Years(—)
- 性别
- All
入选标准
- •Healthy individuals (male or female) 18 – 55 years who are able to provide written consent to participate in this study will be selected from this study.
排除标准
- •Participants will be excluded if they are unwilling or unable to provide written consent or comply with the study procedures. Participants will also be excluded if they have known hypersensitivity or intolerance to caffeine, blackcurrants or berryfruit-derived products. In addition, participants will be excluded if they are pregnant, planning to get pregnant in the immediate future or have any of the following conditions: (i) blood borne diseases (e.g. hepatitis), (ii) clinically diagnosed high/low blood pressure, (iii) recent bacterial or viral illness or (iv) are taking medication that affects the properties of blood (e.g. blood clotting).
